ICAM1 and cystic fibrosis: It remains to be seen whether the differential TSS usage in CF ICAM1 leads to functionally distinct protein isoforms and whether this has an impact on the ability of these cells to carry out efferocytosis, a process known to be inefficient in CF inflammation generally.